Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06171386 · ClinicalTrials.gov registry record · NA
Microneedling vs Dermabrasion for Early Facial Scar Resurfacing
A NA study of Scar, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06171386: Recruiting NA study of Scar, sponsored by Wake Forest University Health Sciences.
NCT06171386 is a NA study of Scar that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 30 participants, below the 47-participant average among 15 other Scar trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06171386, a NA study of Scar, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to determine whether microneedling or dermabrasion in the early post-operative period is superior in improving the appearance of surgical scars on the face.
Primary Outcome
Four characteristics of the scar are assessed. These are: vascularity, height, pliability, and pigmentation. Each characteristic is given a score, which are added together to give an overall score between 0 and 13 - lower scores denoting normal skin
Conditions Studied
Interventions
- PROCEDURE Microneedling
- PROCEDURE Dermabrasion
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2026-04 |
| Phase | NA |
What NCT06171386 shows while recruiting
NCT06171386 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 47-participant average among 15 other Scar trials with a reported enrollment target (36% lower).
The record links to 1 condition, with Scar appearing as the primary indexed condition, and to 2 interventions - of which Microneedling is the first listed.
NCT06171386 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06171386 about?
NCT06171386 is a clinical study titled "Microneedling vs Dermabrasion for Early Facial Scar Resurfacing". This study aims to determine whether microneedling or dermabrasion in the early post-operative period is superior in improving the appearance of surgical scars on the face.
What is the current status of trial NCT06171386?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-04-01. Estimated completion is 2026-04.
What conditions does trial NCT06171386 study?
This clinical trial studies the following conditions: Scar.
What interventions are being tested in trial NCT06171386?
The interventions under investigation include: Microneedling (PROCEDURE), Dermabrasion (PROCEDURE).
Who is sponsoring clinical trial NCT06171386?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06171386 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Scar
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06171386's enrollment target sits among peer trials
30 8th of 15 higher than 5 of 15 other Scar trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Scar trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Paraffin Wax and Exercise Prospective
RECRUITING · NA
-
Impact of Suture Type on Pigment Disturbances in Patients of Skin of Color
RECRUITING · NA
-
CO2 Laser Revision for Burn Related Donor Site Scars
ACTIVE NOT RECRUITING · NA
-
Influence of Sun Protection and Linear Repair of Cutaneous Surgical Defects
ACTIVE NOT RECRUITING · NA
-
PDL and Fractional Photothermolysis for Postsurgical Scars
ACTIVE NOT RECRUITING · NA
-
Pilot Study Investigating a Restorative Wound Care Cream Together With Petrolatum on Surgical Excisions
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI